Eczema Trial, Recruiting NCT06943469 Sponsor: Société des Produits Nestlé (SPN) Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT06943469
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A parent or legal guardian has agreed to take part by signing a consent form
  • The baby was born at full term (at least 37 weeks of pregnancy)
  • The baby weighed between 2.5 kg and 4.5 kg (approximately 5.5 to 9.9 lbs) at birth
  • The baby is no more than 14 days old when joining the trial
  • The baby is a single birth, or if from a multiple birth (e.g., twins), all siblings from that birth are enrolled together
  • At least one biological parent or sibling has been medically diagnosed with an allergy (confirmed through a short questionnaire)
  • Either: the baby has been exclusively breastfed since birth and the parent plans to continue exclusive breastfeeding until at least 4 months old — OR — the baby has been mainly or fully formula-fed in the 24 hours before joining (at least 75% of feeds being formula), and the parents made this choice on their own before the trial
  • Parents or guardians can prove their identity and parental authority
  • Parents or guardians are able to understand the study documents and are willing to follow the study requirements

Who may not be able to join:

  • The baby has an infection, metabolic condition, birth defect, genetic condition, digestive illness, or any other health issue (such as gut surgery) that could affect feeding, growth, or the study results
  • The baby needs a special type of formula (such as extensively broken-down protein formula or formula for metabolic diseases) or needs to be fed through a tube
  • The baby has already been diagnosed by a doctor with any allergy, including eczema (atopic dermatitis) or cow's milk allergy
  • The baby is currently in, or has previously taken part in, another clinical trial
  • Either parent or legal guardian is under 18 years of age

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41217858939

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Société des Produits Nestlé (SPN)
Registry
ClinicalTrials.gov
Start date
10 April 2025
Est. completion
1 October 2027

Where this trial is recruiting

🇧🇪 Belgium 🇫🇷 France 🇩🇪 Germany 🇪🇸 Spain

Primary endpoints

TransEpidermal Water Loss (TEWL) at 3 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov